Biocon shares rise after securing 10-year Pertuzumab supply contract in Brazil
Biocon Ltd. shares gained after the company secured a 10-year supply contract for Pertuzumab in Brazil. It signed a partnership agreement with Bahiafarma and Bionovis for the breast cancer treatment drug.
Biocon Ltd. shares gained on Tuesday, September 8, after the company said it has secured a 10-year supply contract for Pertuzumab in Brazil. The company said it has signed a partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil, describing it as an important milestone in advancing pro…